Dietary factors and the risk for acute infant leukemia: Evaluating the effects of cocoa-derived flavanols on DNA topoisomerase activity

Experimental Biology and Medicine

Volumn 235, Issue 1, 2010, Pages 77-89

  Lanoue, Louise ^a   Green, Kerri K ^a   Kwik Uribe, Catherine ^b   Keen, Carl L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MARS INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute leukemia; Flavanols; Flavonoids; Reproduction; Topoisomerase II; Toxicity

Indexed keywords

CATECHIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); EPICATECHIN; ETOPOSIDE; FLAVONOID; FLAVONOL; OLIGOMER; POISON; POLYPHENOL DERIVATIVE; PROCYANIDIN; QUERCETIN;

ACUTE LEUKEMIA; ARTICLE; BONE MARROW CELL; CACAO; CANCER CELL CULTURE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DIETARY INTAKE; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOID CELL; RISK ASSESSMENT;

CACAO; CELL LINE; DIET; DIMERIZATION; DNA TOPOISOMERASES, TYPE II; ETOPOSIDE; FEMALE; FLAVONOIDS; HL-60 CELLS; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; QUERCETIN; RISK FACTORS;

THEOBROMA CACAO;

EID: 76749106057     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2009.009184     Document Type: Article

References (68)

1. Balzer J, Rassaf T, Heiss C, Kleinbongard P, Lauer T, Merx M, Heussen N, Gross HB, Keen CL, Schroeter H, Kelm M. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol 2008;51:2141-9
2. Corder R, Mullen W, Khan NQ, Marks SC, Wood EG, Carrier MJ, Crozier A. Oenology: red wine procyanidins and vascular health. Nature 2006;444:566
3. Corder R. Red wine, chocolate and vascular health: developing the evidence base. Heart 2008;94:821-3
4. Grassi D, Aggio A, Onori L, Croce G, Tiberti S, Ferri C, Ferri L, Desideri G. Tea, flavonoids, and nitric oxide-mediated vascular reactivity. J Nutr 2008;138:1554S-60S
5. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007;85:895-909
6. Moon YJ, Wang X, Morris ME. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 2006;20:187-210
7. Mursu J, Nurmi T, Tuomainen TP, Salonen JT, Pukkala E, Voutilainen S. Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Cancer 2008;123:660-3
8. Nichenametla SN, Taruscio TG, Barney DL, Exon JH. A review of the effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr 2006;46:161-83
9. Nurk E, Refsum H, Drevon CA, Tell GS, Nygaard HA, Engedal K, Smith AD. Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr 2009;139:120-7
10. Perez-Vizcaino F, Duarte J, Andriantsitohaina R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic Res 2006;40:1054-65
11. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 2006;103:1024-9
12. Erdman JW Jr, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, Harnly J, Hollman P, Keen CL, Mazza G, Messina M, Scalbert A, Vita J, Williamson G, Burrowes J. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr 2007;137:718S-37S
13. Felix CA, Kolaris CP, Osheroff N. Topoisomerase II and the etiology of chromosomal translocations. DNA Repair (Amst) 2006;5:1093-108
14. Ross JA, Potter JD, Robison LL. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst 1994;86:1678-80
15. Tower RL, Spector LG. The epidemiology of childhood leukemia with a focus on birth weight and diet. Crit Rev Clin Lab Sci 2007;44:203-42
16. Jensen CD, Block G, Buffler P, Ma X, Selvin S, Month S. Maternal dietary risk factors in childhood acute lymphoblastic leukemia (United States). Cancer Causes Control 2004;15:559-70
17. Spector LG, Xie Y, Robison LL, Heerema NA, Hilden JM, Lange B, Felix CA, Davies SM, Slavin J, Potter JD, Blair CK, Reaman GH, Ross JA. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev 2005;14:651-5
18. Austin CA, Patel S, Ono K, Nakane H, Fisher LM. Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem J 1992;282(Part 3):883-9
19. Bandele OJ, Osheroff N. Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry 2007;46:6097-108
20. Bandele OJ, Clawson SJ, Osheroff N. Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement. Chem Res Toxicol 2008;21:1253-60
21. Constantinou A, Mehta R, Runyan C, Rao K, Vaughan A, Moon R. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J Nat Prod 1995;58:217-25
22. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia [see comments]. Proc Natl Acad Sci USA 2000;97:4790-5
23. Ross JA. Dietary flavonoids and the MLL gene: a pathway to infant leukemia? [comment]. Proc Natl Acad Sci USA 2000;97:4411-3
24. Mueller-Planitz F, Herschlag D. Coupling between ATP binding and DNA cleavage by DNA topoisomerase II: A unifying kinetic and structural mechanism. J Biol Chem 2008;283:17463-76
25. McClendon AK, Osheroff N. DNA topoisomerase II, genotoxicity, and cancer. Mutat Res 2007;623:83-97
26. Schoeffler AJ, Berger JM. Recent advances in understanding structure-function relationships in the type II topoisomerase mechanism. Biochem Soc Trans 2005;33:1465-70
27. Kellner U, Sehested M, Jensen PB, Gieseler F, Rudolph P. Culprit and victim - DNA topoisomerase II. Lancet Oncol 2002;3:235-43
28. Robert J, Larsen AK. Drug resistance to topoisomerase II inhibitors. Biochimie 1998;80:247-54
29. Wilstermann AM, Bender RP, Godfrey M, Choi S, Anklin C, Berkowitz DB, Osheroff N, Graves DE. Topoisomerase II - drug interaction domains: identification of substituents on etoposide that interact with the enzyme. Biochemistry 2007;46:8217-25
30. Emerenciano M, Koifman S, Pombo-de-Oliveira MS. Acute leukemia in early childhood. Braz J Med Biol Res 2007;40:749-60
31. Greaves M. Pre-natal origins of childhood leukemia. Rev Clin Exp Hematol 2003;7:233-45
32. Lightfoot TJ, Roman E. Causes of childhood leukaemia and lymphoma. Toxicol Appl Pharmacol 2004;199:104-17
33. Aplan PD. Causes of oncogenic chromosomal translocation. Trends Genet 2006;22:46-55
34. Chowdhury T, Brady HJ. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia. Blood Cells Mol Dis 2008;40:192-9
35. Greaves M. In utero origins of childhood leukaemia. Early Hum Dev 2005;81:123-9
36. Ross JA. Environmental and genetic susceptibility to MLL-defined infant leukemia. J Natl Cancer Inst Monogr 2008;39:83-6
37. Sung PA, Libura J, Richardson C. Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions. DNA Repair (Amst) 2006;5:1109-18
38. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood 2003;102:2321-33
39. Rowley JD. Chromosome translocations: dangerous liaisons revisited. Nat Rev Cancer 2001;1:245-50
40. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control 1996;7:581-90
41. Aron PM, Kennedy JA. Flavan-3-ols: nature, occurrence and biological activity. Mol Nutr Food Res 2008;52:79-104
42. Holt RR, Lazarus SA, Sullards MC, Zhu QY, Schramm DD, Hammerstone JF, Fraga CG, Schmitz HH, Keen CL. Procyanidin dimer B2 [epicatechin-(4beta-8)- epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr 2002;76:798-804
43. Triche EW, Grosso LM, Belanger K, Darefsky AS, Benowitz NL, Bracken MB. Chocolate consumption in pregnancy and reduced likelihood of preeclampsia. Epidemiology 2008;19:459-64
44. Snyder RD, Arnone MR. Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mutat Res 2002;503:21-35
45. Ferguson LR. Role of plant polyphenols in genomic stability. Mutat Res 2001;475:89-111
46. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 2007;137:1244-52
47. Cooper KA, Donovan JL, Waterhouse AL, Williamson G. Cocoa and health: a decade of research. Br J Nutr 2008;99:1-11
48. Jo JY, Gonzalez de Mejia E, Lila MA. Effects of grape cell culture extracts on human topoisomerase II catalytic activity and characterization of active fractions. J Agric Food Chem 2005;53:2489-98
49. Ramirez-Mares MV, Chandra S, de Mejia EG. In vitro chemopreventive activity of Camellia sinensis, Ilex paraguariensis and Ardisia compressa tea extracts and selected polyphenols. Mutat Res 2004;554:53-65
50. Gonzalez de Mejia E, Song YS, Ramirez-Mares MV, Kobayashi H. Effect of Yerba mate (Ilex paraguariensis) tea on topoisomerase inhibition and oral carcinoma cell proliferation. J Agric Food Chem 2005;53:1966-73
51. Jo JY, de Mejia EG, Lila MA. Cytotoxicity of bioactive polymeric fractions from grape cell culture on human hepatocellular carcinoma, murine leukemia and non-cancerous PK15 kidney cells. Food Chem Toxicol 2006;44:1758-67
52. Jo JY, Gonzalez de Mejia E, Lila MA. Catalytic inhibition of human DNA topoisomerase II by interactions of grape cell culture polyphenols. J Agric Food Chem 2006;54:2083-7
53. Quideau S, Jourdes M, Lefeuvre D, Montaudon D, Saucier C, Glories Y, Pardon P, Pourquier P. The chemistry of wine polyphenolic C-glycosidic ellagitannins targeting human topoisomerase II. Chemistry 2005;11:6503-13
54. Bandele OJ, Osheroff N. (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases. Chem Res Toxicol 2008;21:936-43
55. Suzuki K, Yahara S, Hashimoto F, Uyeda M. Inhibitory activities of (-)-epigallocatechin-3-O-gallate against topoisomerases I and II. Biol Pharm Bull 2001;24:1088-90
56. Heiss C, Finis D, Kleinbongard P, Hoffmann A, Rassaf T, Kelm M, Sies H. Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol 2007;49:74-80
57. Schewe T, Steffen Y, Sies H. How do dietary flavanols improve vascular function? A position paper. Arch Biochem Biophys 2008;476:102-6
58. Wang JF, Schramm DD, Holt RR, Ensunsa JL, Fraga CG, Schmitz HH, Keen CL. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr 2000;130:2115S-9S
59. Actis-Goretta L, Romanczyk LJ, Rodriguez CA, Kwik-Uribe C, Keen CL. Cytotoxic effects of digalloyl dimer procyanidins in human cancer cell lines. J Nutr Biochem 2008;19:797-808
60. Spencer JP, Schroeter H, Shenoy B, Srai SK, Debnam ES, Rice-Evans C. Epicatechin is the primary bioavailable form of the procyanidin dimers B2 and B5 after transfer across the small intestine. Biochem Biophys Res Commun 2001;285:588-93
61. Spencer JP. Metabolism of tea flavonoids in the gastrointestinal tract. J Nutr 2003;133:3255S-61S
62. Yang CS, Sang S, Lambert JD, Lee MJ. Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res 2008;52(Suppl. 1):S139-51
63. Schroeter H. Flavonoids: neuroprotective agents? Modulation of oxidative stress-induced MAP Kinase signal transduction. In: Packer CR-EaL, ed. Flavonoids in Health and Disease. New York: Marcel Dekker, 2004:233-72
64. Spencer JP, Abd-el-Mohsen MM, Rice-Evans C. Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 2004;423:148-61
65. Chu KO, Wang CC, Chu CY, Chan KP, Rogers MS, Choy KW, Pang CP. Pharmacokinetic studies of green tea catechins in maternal plasma and fetuses in rats. J Pharm Sci 2006;95:1372-81
66. Chu KO, Wang CC, Chu CY, Choy KW, Pang CP, Rogers MS. Uptake and distribution of catechins in fetal organs following in utero exposure in rats. Hum Reprod 2007;22:280-7
67. Keen CL, Hanna LA, Lanoue L, Uriu-Adams J, Rucker RB, Clegg MS. Developmental consequences of trace mineral deficiencies in rodents: acute and long-term effects. J Nutr 2003;133:1477S-80S
68. Smith MA, Gloeckler-Ries LA, Gurney JG, Ross JA. Leukemia. SEER Pediatric Monograph, NIH Pub 99-4649, 1999